CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

Clinical trial NCT03051841 · UNKNOWN

Trial details

NCT number: NCT03051841
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloma, Multiple

Start date: 2017-01-01
Primary completion: 2021-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.